MB

Michael Brian Bell

Director Nominee Director DIN 01236600
DIN 01236600 First appointment Oct 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2006
Shareholding value •••• Premium profile

About Michael Brian Bell

Data last updated:

Michael Brian Bell was a Nominee Director at Chiron Behring Vaccines Private Limited (2006–2008) and Nominee Director at Chiron Panacea Vaccines Private Limited (2007–2008). The companies operate in Pharma and Chemicals.

DIN 01236600
Primary Designation Nominee Director
Industry Pharma
First Appointment 06 Oct 2006

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director06 Oct 20061997₹94.53 Cr (FY 2025)Active
Nominee Director14 Jun 20072004Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chiron Behring Vaccines Private Limited
Chiron Panacea Vaccines Private Limited
Premium access

Shareholding and investment profile for Michael Brian Bell

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Michael Brian Bell

Michael Brian Bell was first appointed on 06 Oct 2006 as Nominee Director at Chiron Behring Vaccines Private Limited. The most recent appointment on record is 14 Jun 2007 at Chiron Panacea Vaccines Private Limited.

Michael Brian Bell held 2 earlier board appointments: Chiron Behring Vaccines Private Limited (Nominee Director, 06 Oct 2006 to 10 Dec 2008); Chiron Panacea Vaccines Private Limited (Nominee Director, 14 Jun 2007 to 22 Sep 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available